DexCom Inc (DXCM NASDAQ) stock market data APIs
$67.4882
3.73(5.5%)
as of June 30, 2026
Try our APIs with
free plan!
DexCom Inc Financial Data Overview
Price chart is built with
Anychart
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Prev. Close
67.4882
Open
71.2138
High
71.5318
Low
67.43
52 wk Range
54.11-89.98
Market Cap
25 989 M
P/E Ratio
28.9056
Shares Outstanding
386 M
Revenue
4 818 M
EPS
0.56
Beta
1.443
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with DexCom Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DexCom Inc data using free add-ons & libraries
Get DexCom Inc Fundamental Data
DexCom Inc Fundamental data includes:
- Net Revenue: 4 818 M
- EBITDA: 1 292 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-04-30
- EPS/Forecast: 0.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DexCom Inc News
New
3 Nasdaq 100 Stocks with Promising Prospects
3 Nasdaq 100 Stocks with Promising Prospects The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at...
Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines
Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines As the Q1 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the patie...
DexCom, Inc. (DXCM) Further Advances Vision of Glucose Biosensing for All
DexCom, Inc. (NASDAQ:DXCM) is among the Best Healthcare Stocks. On June 23, DexCom, Inc. (NASDAQ:DXCM) announced that the FDA cleared growing use of its Stelo Glucose Biosensor beyond adults for chil...
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus
Wall Street's major indexes ended lower on Friday as the technology sector continued its selloff after mounting concerns over elevated AI-related valuations and OpenAI considering pausing its IPO unti...
Get DexCom Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
